Sorriso Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 22, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $31,000,000
Company Info
- Founders
- Ciara Kennedy
- Company Description
- Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn's disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system.
- Market
- Inflammatory disease treatment
- Location
- Salt Lake City, UT, USA
- Coinvestors
- Arix Bioscience, New Enterprise Associates